Hematology

Filter

gene therapy

EAHAD 2026: Nine-Year Outcomes of Gene Therapy

February 2026

Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.

Gene Therapy Enables Transfusion Independence in β-Thalassaemia

Innovative gene therapy has been shown to promote transfusion independence in 90% of patients with transfusion-dependant β-thalassaemia…

Novel Personalised Test Facilitates Early Leukaemia Relapse Detection

Personalised testing in acute lymphoblastic leukaemia has been developed to allow for earlier and more accurate prediction of relapse…

Latest Advancements in Gene Therapy for the Treatment of Haemophilia

We explore the latest advancements in gene therapy for the treatment of haemophilia, including what the future of gene therapy could mean for clinicians…

Direct Oral Anticoagulants in the Treatment of Cancer-Related Venous Thromboembolism: Patient Cases

In this episode, we have two experts in the field of direct oral anticoagulants for the treatment of cancer related venous thromboembolisms.

EMJ

The Search for Sustained Durability in Higher-Risk Myelodysplastic Syndrome: New Treatment Pathways in Sight

Higher-risk MDS is a collective term based on the Revised International Prognostic Scoring System (IPSS-R) that encompasses…

ASH Highlights: An Experts Review

In this podcast, Dr. Subarna Chakravorty and Dr. Rachel Kesse-Adu discuss their highlights from ASH surrounding sickle cell disease.

New Treatment Found for Relapsed or Refractory Peripheral T-cell Lymphoma

New research demonstrates that the use of tipifarnib as a treatment for peripheral T-cell lymphoma showed an increase in survival rates…

Digital Necrosis in Multiple Myeloma

Multiple myeloma (MM) is a B cell malignancy characterised by abnormal proliferation of plasma cells that expand in the bone marrow…

Loading posts...

« Previous 1 … 59 60 61 62 63 … 100 Next »